My last post, reviewing 2020, observed that my performance is, superficially at least, very similar to Vanguard’s WoRLd equity tracker ETF VWRL. Despite my portfolio involving a helluva lot more complexity/faff. My post elicited this comment from Bob:
Thanks for sharing, intriguing as always. As someone who recently (18 months ago) simplified my portfolio into three holdings: 1 VWRL seven figures, 2 [single megacap tech stock] six figures, 3 Vanguard Global Bond six figures. I find myself reading about your complexity and not feeling jealous one bit. So the question is, why do you dislike VWRL (or similar global tracker) so much? You mention the comparison several times, what is stopping you making the change? That is after all what reviews should lead to e.g. insights, and change.
Bob, commenting on 2 January 2020
Bob’s challenge is a good one. Why wouldn’t I just swap out my entire portfolio for, say, holding only a single world equities tracking ETF like VWRL or its non-Vanguard equivalents (see Monevator’s updated list of alternatives here, or the SRI alternatives listed on my ETFs page)?
The end of December 2020. Time to do my monthly review of my portfolio, but also time to do an annual review. It is the end of my eighth year of monthly tracking of my portfolio. And it’s the first year I’ve tracked that has a very serious market meltdown in it, triggered of course by the covid-19 pandemic.
While I am somewhat geeky unusual in the attention I pay to my portfolio, it is general good practice even for ‘normal people’ to review their finances and investments on an annual basis. In the spirit of trying to be helpful, I’m setting out in this post to tackle seven generic questions that I think all prudent investors should ask themselves at least annually, and where the answers suggest ways to optimise/enhance your outcomes.
November saw the second national lockdown in England.
Most shops closed. All pubs/restaurants closed. Hair dressers closed. No social mixing indoors, and max 1 person to be met up with outside. Not a whole lot of fun. The weather has been relatively nice to us – it’s been damp and chilly, but not unrelentingly so. I’ve found some new parts of London.
At work, we assumed things would turn downwards – as business became harder to do. But in fact we were busy in November. Much busier than we expected.
Trump is now officially a loser. It feels hard to describe Biden as a winner – perhaps I know how Trump feels? – but it is certainly easy to describe Trump as a loser.
But the word of the month has been Vaccines. Both an expensive Pfizer/BioNTech one, and a ‘good enough, and easy enough, and cheap enough’ one from Oxford University/AstraZeneca. Suddenly the mood music has changed very much for the better.